Skip to main content
Premium Trial:

Request an Annual Quote

Open Medicine Foundation Commits $1.8M to Research ME/CFS at Harvard Hospitals

NEW YORK (GenomeWeb) – The Open Medicine Foundation (OMF) announced today that it has committed $1.8 million to support the creation of a new myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) research center at Harvard Medical School-affiliated hospitals.

The new center — which will be led by OMF scientific advisory board member Ronald Tompkins and Harvard's Wenzhong Xiao — will be tasked with generating molecular data on muscle and other tissues affected by ME/CFS using genomics, proteomics, and ultrastructural analysis, according to OMF. It will also facilitate multi-center clinical studies on potential effective treatments for the conditions.

In December, OMF put up $1.2 million to fund the first year of operations for a newly established ME/CFS collaborative research center at Stanford University. The organization has also recently provided funding to expand the Stanford Data Center for the Severely Ill Patients study to include any data from its sponsored research initiatives.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.